The Cancer Letter

Inside information on cancer research and drug development

What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.”

In Brief

Jennifer Bickel named vice president and chief wellness officer at MD Anderson

Lorenzo Galluzzi joins Cancer Signaling and Microenvironment Research Program at Fox Chase

UMich Rogel Cancer Center receives $50M for pancreatic cancer care, research

UCLA researchers awarded $2.5M grant from BMS Foundation to increase lung cancer screening in underserved communities

MD Anderson’s Boot Walk to End Cancer raises $1.4M

UChicago receives $75M from AbbVie Foundation for construction of the cancer care and research pavilion

Drugs & Targets

FDA approves MI Cancer Seek as a CDx test for adults and pediatric patients

FDA approves Scemblix for newly diagnosed CML patients

Pangea Biomed, OHSU Knight Cancer Institute collaborate to improve cancer therapy precision

FDA approves Vyloy+chemo for gastric or GEJ junction adenocarcinoma with CLDN18.2-positive tumors

FDA accepts NDA, grants priority review for Pixclara glioma imaging agent

EC approves Keytruda combinations for endometrial carcinoma indication, FIGO 2014 stage III-IVA locally advanced cervical cancer

In The Clinic
Trials & Tribulations

Addressing high cancer mortality in Native Hawaiian and Pacific Islander populations
A call for equity in cancer research

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account